Eluciderm, Inc., a clinical-stage pharmaceutical company developing small molecule therapeutics designed to promote healing and regenerative repair of injured tissue, announced today that on June 30, ...

BioLab Holdings, Inc. recently announced the launch of a multicenter hybrid platform trial evaluating the clinical real-world ...

Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore ...

Diabetic foot ulcer recurrence may now be more predictable due to a study that identifies compromised skin barrier function ...

Venture Medical, LLC, a leader in advanced wound care solutions, today announced the closing of a strategic investment in ...

In combat zones and emergency rescues, rapid evacuation and treatment can mean the difference between life and death. But ...

Diabetic foot ulcer (DFU) are a severe complication in diabetic patients, requiring accurate and early diagnosis to prevent further complications such as infection or amputation. To address this, ...

High transepidermal water loss with a cutoff of 30.05 g/m2/h was associated with a higher risk for diabetic foot ulcer recurrence.

Growth factors like epidermal and platelet-derived types showed strong benefits in accelerating healing and reducing ...

What is Helicobacter pylori (H. pylori)? Helicobacter pylori (H. pylori) is a type of bacteria that infects your stomach. It can damage the tissue in your stomach and the first part of your small ...

Severity stage classification of diabetic foot ulcers is a vital way to improve the decision support on treatment planning and diagnostic performance. Nevertheless, the precise manual identification ...